Dergiler / Şişli Etfal Hastanesi Tıp Bülteni / 2019 / Cilt: 53 - Sayı: 4

Development of Multiple-Lesion Basal Cell Carcinoma of the Skin: A Comprehensive Review

Sayfa
323–328
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

A reliable prediction model for individualized riskstratification remains a subject of continued research; however, a focus on the risk factor profile is beneficial for clinical screeningand may help clinicians to determine the individuals who should be followed up more closely.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:An interesting clinical feature of basal cell carcinoma (BCC) of the skin is a marked variation in tumor number, sites, and accrual.Some individuals develop only a single BCC lesion with no impact on health status, while a significant proportion is affectedrepeatedly with new primary tumors at various body sites.
📊
Temel Bulgular & Veri:Approximately 29% of patients with a first BCC will develop at least 1more lesion during their lifetime.
💡
Sonuç & Katkı:A reliable prediction model for individualized riskstratification remains a subject of continued research; however, a focus on the risk factor profile is beneficial for clinical screeningand may help clinicians to determine the individuals who should be followed up more closely.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

An interesting clinical feature of basal cell carcinoma (BCC) of the skin is a marked variation in tumor number, sites, and accrual.Some individuals develop only a single BCC lesion with no impact on health status, while a significant proportion is affectedrepeatedly with new primary tumors at various body sites. Approximately 29% of patients with a first BCC will develop at least 1more lesion during their lifetime. The candidate predictors for multiple BCC development include younger age and a superficialBCC subtype at the time of the first diagnosis, red hair phenotype, initial or frequent tumor location on the trunk or on the upperlimbs, and male gender. The pathogenesis of multiple BCC development does not seem to be related to greater UVR exposure.Individual genetic susceptibility may have a greater impact than extrinsic factors. In clinical practice, it is meaningful to estimatethe probability of new BCC development in patients who have an initial lesion. A reliable prediction model for individualized riskstratification remains a subject of continued research; however, a focus on the risk factor profile is beneficial for clinical screeningand may help clinicians to determine the individuals who should be followed up more closely.

🔖

Bu Makaleye Atıf Yap

BARTOS, V. (2019). Development of Multiple-Lesion Basal Cell Carcinoma of the Skin: A Comprehensive Review. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 53 - Sayı: 4, 323–328. https://ajindex.com/articles/364181

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC. Molecular aetiology and pathogenesis of basal cell carcinoma. Br J Dermatol 2005;152:1108–24
  2. Khalesi M, Whiteman DC, Doi SA, Clark J, Kimlin MG, Neale RE. Cutaneous markers of photo-damage and risk of Basal cell carcinoma of the skin: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2013;22:1483–9
  3. Ramachandran S, Fryer AA, Smith AG, Lear JT, Bowers B, Griffiths CE, et al. Basal cell carcinoma. Cancer 2000;89:1012–8
  4. Ramachandran S, Fryer AA, Strange RC. Genetic factors determining cutaneous basal cell carcinoma phenotype. Med Pediatr Oncol 2001;36:559–63
  5. Ramachandran S, Fryer AA, Smith A, Lear J, Bowers B, Jones PW, et al. Cutaneous basal cell carcinomas: distinct host factors are associated with the development of tumors on the trunk and on the head and neck. Cancer 2001;92:354–8
  6. Adachi K, Yoshida Y, Noma H, Goto H, Yamamoto O. Characteristics of multiple basal cell carcinomas: The first study on Japanese patients. J Dermatol 2018;45:1187–90
  7. Kiiski V, de Vries E, Flohil SC, Bijl MJ, Hofman A, Stricker BH, et al. Risk factors for single and multiple basal cell carcinomas. Arch Dermatol 2010;146:848–55
  8. Verkouteren JAC, Smedinga H, Steyerberg EW, Hofman A, Nijsten T. Predicting the Risk of a Second Basal Cell Carcinoma. J Invest Dermatol 2015;135:2649–56
  9. Richmond-Sinclair NM, Pandeya N, Ware RS, Neale RE, Williams GM, van der Pols JC, et al. Incidence of basal cell carcinoma multiplicity and detailed anatomic distribution: longitudinal study of an Australian population. J Invest Dermatol 2009;129:323–8
  10. Raasch BA, Buettner PG. Multiple nonmelanoma skin cancer in an exposed Australian population. Int J Dermatol 2002;41:652–8
  11. Mantese OAS, Gomides ADM, Berbert VCLA, Rocha A. Basal cell carcinoma – analysis of 300 cases observed in Uberlândia - MG, Brazil. An Bras Dermatol 2006;81:136–42
  12. Stang A, Ziegler S, Büchner U, Ziegler B, Jöckel KH, Ziegler V. Malignant melanoma and nonmelanoma skin cancers in NorthrhineWestphalia, Germany: a patient- vs. diagnosis-based incidence approach. Int J Dermatol 2007;46:564–70
  13. Flohil SC, Koljenović S, de Haas ER, Overbeek LI, de Vries E, Nijsten T. Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands. Br J Dermatol 2011;165:874–81
  14. Souza CF, Thomé EP, Menegotto PF, Schmitt JV, Shibue JR, Tarlé RG. Topography of basal cell carcinoma and their correlations with gender, age and hist